Discovery of ‘vehicle peptide’ could help target drug-resistant cancers
Scientists at Tokyo Medical and Dental University have discovered a cyclic decapeptide with the ability to transport anticancer peptides into cancer cells.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.